Cargando…
A New Insight into Meloxicam: Assessment of Antioxidant and Anti-Glycating Activity in In Vitro Studies
Meloxicam is a non-steroidal anti-inflammatory drug, which has a preferential inhibitory effect to cyclooxyganase-2 (COX-2). Although the drug inhibits prostaglandin synthesis, the exact mechanism of meloxicam is still unknown. This is the first study to assess the effect of meloxicam on protein gly...
Autores principales: | Pawlukianiec, Cezary, Gryciuk, Małgorzata Ewa, Mil, Kacper Maksymilian, Żendzian-Piotrowska, Małgorzata, Zalewska, Anna, Maciejczyk, Mateusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558080/ https://www.ncbi.nlm.nih.gov/pubmed/32927809 http://dx.doi.org/10.3390/ph13090240 |
Ejemplares similares
-
Pleiotropic Properties of Valsartan: Do They Result from the Antiglycooxidant Activity? Literature Review and In Vitro Study
por: Mil, Kacper Maksymilian, et al.
Publicado: (2021) -
Salivary Redox Biomarkers in Insulin Resistance: Preclinical Studies in an Animal Model
por: Maciejczyk, Mateusz, et al.
Publicado: (2021) -
Antioxidant and Anti-Glycation Potential of H2 Receptor Antagonists—In Vitro Studies and a Systematic Literature Review
por: Biedrzycki, Grzegorz, et al.
Publicado: (2023) -
α-Lipoic Acid Strengthens the Antioxidant Barrier and Reduces Oxidative, Nitrosative, and Glycative Damage, as well as Inhibits Inflammation and Apoptosis in the Hypothalamus but Not in the Cerebral Cortex of Insulin-Resistant Rats
por: Maciejczyk, Mateusz, et al.
Publicado: (2022) -
High Protein Diet Induces Oxidative Stress in Rat Cerebral Cortex and Hypothalamus
por: Żebrowska, Ewa, et al.
Publicado: (2019)